The Senate voted 51, 44 to confirm Dr. Erica Schwartz as the 22nd director of the Centers for Disease Control and Prevention, ending nearly a year of leadership turmoil at the nation's top public health agency.
Wednesday's mostly party-line vote gave the CDC its first permanent director since Susan Monarez was fired last August after clashing with Health and Human Services Secretary Robert F. Kennedy Jr. over childhood vaccine policy. Sen. Tim Kaine of Virginia was the only Democrat to cross over and vote in Schwartz's favor, The Hill reported.
Schwartz inherits an agency in rough shape. The CDC has shed more than a quarter of its workforce, over 3,000 employees, through layoffs and resignations since President Trump returned to office. Active outbreaks of measles and the largest-ever recorded surge of cyclosporiasis, a diarrhea-causing parasite linked to contaminated lettuce, are testing an agency already stretched thin.
For conservatives who have spent years demanding accountability from a CDC that bungled its COVID-era credibility, the question is straightforward: Can Schwartz restore the agency's scientific credibility while keeping it out of political activism?
Schwartz is Trump's third nominee for the CDC job. Dave Weldon, a former Florida congressman and the administration's first choice, withdrew after it became clear he lacked the votes. Questions about his preparedness and his views on vaccination doomed his bid before it reached the floor.
Trump nominated Schwartz in April, calling her a "highly respected" doctor with the "knowledge, experience, and TOP degrees to restore the GOLD STANDARD OF SCIENCE at the CDC," the New York Post reported.
Her résumé gave skeptics less to work with than Weldon's had. Schwartz served as deputy surgeon general during Trump's first term and held a senior health post in the Coast Guard. She publicly supported childhood vaccines, a fact that mattered in the confirmation fight, given Kennedy's well-known skepticism.
The broader push to fill vacancies across the administration has been a defining feature of Senate Republicans' work this year, with leadership racing to clear nominees before recesses and avoid the kind of drawn-out battles that plagued earlier picks.
The most consequential Republican voice in the process belonged to Sen. Bill Cassidy of Louisiana, who chairs the Senate Committee on Health, Education, Labor and Pensions. Cassidy, a physician himself, made clear during Schwartz's July hearing that he expected the next CDC director to defend vaccine science against political pressure, from any direction.
Cassidy told the hearing room bluntly:
"We need a CDC director that will actually stand up to crazy, stupid things being said that undermine faith in immunization."
But Schwartz's answers left him unsatisfied. Cassidy said her responses were "not quite the direct answer" he had been looking for, particularly on whether she would push back against Kennedy's vaccine policies. Democrats seized on the same concern, questioning whether Schwartz had the independence to resist directives from HHS that could undermine public health.
What moved Cassidy from skeptic to supporter was a specific, concrete change: the CDC modified a webpage addressing vaccines and autism. The update addressed Cassidy's objections, and after additional conversations with Schwartz and people who knew her professional record, the chairman said he was satisfied.
Cassidy announced his support with a statement that carried both endorsement and warning:
"I'm confident that she knows what she is doing and will stand against those who do not."
That backing cleared the path. With Cassidy on board, the nomination moved to the floor without a Republican defection.
Several senators missed the vote entirely. The Washington Examiner noted that Republicans Ron Johnson, Thom Tillis, and Mitch McConnell were among those who did not vote, accounting for the slight discrepancy between reported tallies of 51, 44 and 51, 43.
Most Democratic opposition had less to do with Schwartz's qualifications than with the man she would report to. Sen. Bernie Sanders laid out the party's core objection at the July hearing:
"The issue at hand is not complicated. Will we have people in the Trump administration who have the guts to stand up to people who are antiscience and into conspiracy theories?"
The subtext was clear. Democrats wanted Schwartz to publicly distance herself from Kennedy's vaccine skepticism, and she declined to do so in the terms they demanded. She told senators she did not believe Kennedy would ask her to do something similar to what led to Monarez's firing, Breitbart reported. She pledged to lead with integrity and "never compromise on the science."
Whether that pledge holds will depend on how Schwartz handles the tension between HHS and the CDC that has defined the past year. Monarez lasted only about a month before her firing over what she described as Kennedy's attempts to roll back childhood vaccines. The revolving door, Schwartz is among nearly half a dozen people to hold or act in the CDC director role during Trump's second term, has left the agency without stable leadership at a moment when it faces real public health emergencies.
Senate Republicans have been working methodically to clear a massive backlog of Trump nominees, and Schwartz's confirmation fits that broader effort. But the CDC job carries unique weight. Unlike many executive branch posts, it sits at the intersection of science, politics, and public trust, a combination that has proved combustible.
The workforce numbers alone tell the story of an agency under strain. More than 3,000 CDC employees have departed since Trump took office, a mix of layoffs and resignations that has hollowed out institutional capacity. The measles outbreak continues. The cyclosporiasis surge is the largest on record. And until Wednesday, no confirmed director was in place to coordinate the response.
Schwartz was notably Trump's personal choice for the role, not Kennedy's, a distinction that public health observers watched closely, given the friction between HHS and the CDC over the past year.
The confirmation battles that have marked this administration's second term, from attorney general nominees facing Senate holdouts to intelligence picks generating resistance, have tested the GOP majority's ability to hold together on floor votes. Schwartz's 51, 44 result shows the majority held, but just barely, and with only a single Democratic crossover.
Open questions remain. What exact changes were made to the CDC's vaccine-autism webpage, and who authorized them? Will Schwartz have the operational independence to run the agency without interference from Kennedy? And can a director who sidestepped direct confrontation during her hearing find the backbone to push back when it matters?
Cassidy's support came with an implicit condition: that Schwartz would defend immunization science against anyone who undermines it. If she does, she will earn the credibility the CDC desperately needs. If she doesn't, the senator who cleared her path will be the first to say he told her so.
The CDC doesn't need another warm body in the director's chair. It needs someone who will stay long enough to do the job, and who understands that restoring public trust means telling the truth, even when the boss doesn't want to hear it.
